About Us

About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alnylam Issues 2024 Corporate Responsibility Report

By: via Business Wire

– Contains New Disclosures of Company’s Impact on the Environment – Including Independently Verified Scope 1, 2, and 3 Multiyear Data on Greenhouse Gas (GHG) Emissions –

– Highlights Progress of Alnylam Challengers Global Health Equity Initiative –

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today the publication of its 2024 Corporate Responsibility Report. Guided by the theme of “Accepting Challenges to Improve the Health of Humanity,” Alnylam continues to take meaningful steps across each of its six corporate responsibility pillars. This year’s edition highlights the company’s progress, data, and stories demonstrating its commitment to patient access, an award-winning culture, innovative science, health equity, and environmental stewardship.

“As we continue to lead the way in RNAi innovation, there is a profound opportunity in front of us to shape the future of medicine and impact the lives of millions of patients. At Alnylam, we believe that making history means advancing groundbreaking science while shaping a healthier, more equitable, and sustainable future for all,” said Yvonne Greenstreet, M.D., Chief Executive Officer of Alnylam.

Key highlights from the 2024 report include:

  • Published new data and activities on reducing Alnylam’s environmental impact.

    Disclosed independently verified multiyear data on scope 1, 2, and 3 GHG emissions as well as multiyear data on energy, water, and waste management footprint. Highlighted the use of 100% renewable energy at Norton and Alewife manufacturing sites.
  • Made continued progress with Alnylam’s global Patient Access Philosophy.

    Revisited the principles of the company’s Patient Access Philosophy in order to reach even more patients. Published both quantitative and qualitative data on key focus areas of value and impact, achieving better outcomes, and being proactive and accountable.
  • Expanded impact of Alnylam Challengers global health equity initiative.

    Demonstrated the programmatic impact of U.S. and European partnerships with social entrepreneurs and non-profit organizations working on the frontlines to address health inequalities through education, training, and the creation of novel tools contributing to long term well-being, health, and stability in impacted communities.
  • Maintained ongoing focus and investment in people and culture.

    Showcased the growth of Employee Resource Networks (ERNs), expanded benefit programs, and enhanced talent recruitment and development initiatives. Published results from the annual Employee Culture Survey, reflecting a strong sense of inclusion and fairness, with 88% of employees affirming that they feel accepted and treated fairly by the company and their peers.

To learn more about corporate responsibility at Alnylam, download the full 2024 Corporate Responsibility Report here.

About Alnylam Pharmaceuticals

Alnylam (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and prevalent diseases with unmet need. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach yielding transformative medicines. Since its founding in 2002, Alnylam has led the RNAi Revolution and continues to deliver on a bold vision to turn scientific possibility into reality. Alnylam’s commercial RNAi therapeutic products include ONPATTRO® (patisiran), AMVUTTRA® (vutrisiran), GIVLAARI® (givosiran), and OXLUMO® (lumasiran), which are being developed and commercialized by Alnylam, and Leqvio® (inclisiran) and Qfitlia™ (fitusiran), which are being developed and commercialized by Alnylam’s partners, Novartis and Sanofi, respectively. Alnylam has a deep pipeline of investigational medicines, including multiple product candidates that are in late-stage development. Alnylam is executing on its “Alnylam P5x25” strategy to deliver transformative medicines in both rare and common diseases benefiting patients around the world through sustainable innovation and exceptional financial performance, resulting in a leading biotech profile. Alnylam is headquartered in Cambridge, MA. For more information about our people, science and pipeline, please visit www.alnylam.com and engage with us on X (formerly Twitter) at @Alnylam, or on LinkedIn, Facebook, or Instagram.

Contacts

Alnylam Pharmaceuticals, Inc.

Christine Regan Lindenboom

(Investors and Media)

+1-617-682-4340

Josh Brodsky

(Investors)

+1-617-551-8276

More News

View More
Etsy Partners With OpenAI—What It Means for Investors Now
Via MarketBeat
Topics Artificial Intelligence
Tickers ETSY
3 Solid Consumer Brands Offering Stability in Volatile Markets
Via MarketBeat
Topics Economy
Tickers AOUT JAKK KO PG SN
Lamb Weston: Is the King of Spuds a Buy or a Dud for 2026?
Via MarketBeat
Tickers LW
Palantir Stock Eyes New Highs, Boosted by Boeing Partnership
Via MarketBeat
Topics Artificial Intelligence
Tickers BA BAC PLTR
Marvell Soars on +$6B in Buybacks—Can the Recovery Continue?
Via MarketBeat
Topics Artificial Intelligence
Tickers AMZN AVGO MRVL
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.